HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
NYSE:DOC - New York Stock Exchange, Inc. - US42250P1030 - REIT - Currency: USD
Taking everything into account, DOC scores 3 out of 10 in our fundamental rating. DOC was compared to 129 industry peers in the Diversified REITs industry. DOC has a medium profitability rating, but doesn't score so well on its financial health evaluation. DOC is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year DOC was profitable.
DOC had a positive operating cash flow in the past year.
Each year in the past 5 years DOC has been profitable.
DOC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
DOC has a Return On Assets of 1.55%. This is in the better half of the industry: DOC outperforms 61.90% of its industry peers.
DOC has a Return On Equity of 3.61%. This is in the better half of the industry: DOC outperforms 62.70% of its industry peers.
With a Return On Invested Capital value of 2.53%, DOC perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
DOC had an Average Return On Invested Capital over the past 3 years of 2.14%. This is in line with the industry average of 3.11%.
The 3 year average ROIC (2.14%) for DOC is below the current ROIC(2.53%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 3.61% | ||
| ROIC | 2.53% |
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
1.3 Margins
DOC has a Profit Margin of 12.08%. This is in the better half of the industry: DOC outperforms 61.90% of its industry peers.
DOC's Profit Margin has declined in the last couple of years.
DOC's Operating Margin of 22.99% is in line compared to the rest of the industry. DOC outperforms 53.17% of its industry peers.
In the last couple of years the Operating Margin of DOC has declined.
The Gross Margin of DOC (64.69%) is worse than 63.49% of its industry peers.
In the last couple of years the Gross Margin of DOC has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.99% | ||
| PM (TTM) | 12.08% | ||
| GM | 64.69% |
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
2. Health
2.1 Basic Checks
DOC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DOC remains at a similar level compared to 1 year ago.
DOC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DOC is higher compared to a year ago.
2.2 Solvency
DOC has an Altman-Z score of 0.56. This is a bad value and indicates that DOC is not financially healthy and even has some risk of bankruptcy.
DOC has a Altman-Z score of 0.56. This is comparable to the rest of the industry: DOC outperforms 46.03% of its industry peers.
DOC has a debt to FCF ratio of 18.44. This is a negative value and a sign of low solvency as DOC would need 18.44 years to pay back of all of its debts.
The Debt to FCF ratio of DOC (18.44) is better than 76.19% of its industry peers.
A Debt/Equity ratio of 1.00 indicates that DOC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.00, DOC is in line with its industry, outperforming 58.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 18.44 | ||
| Altman-Z | 0.56 |
ROIC/WACC0.36
WACC7.05%
2.3 Liquidity
A Current Ratio of 0.15 indicates that DOC may have some problems paying its short term obligations.
DOC's Current ratio of 0.15 is on the low side compared to the rest of the industry. DOC is outperformed by 99.21% of its industry peers.
DOC has a Quick Ratio of 0.15. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
DOC's Quick ratio of 0.15 is on the low side compared to the rest of the industry. DOC is outperformed by 99.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.15 | ||
| Quick Ratio | 0.15 |
3. Growth
3.1 Past
DOC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.82%.
Measured over the past years, DOC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.07% on average per year.
Looking at the last year, DOC shows a quite strong growth in Revenue. The Revenue has grown by 18.79% in the last year.
Measured over the past years, DOC shows a quite strong growth in Revenue. The Revenue has been growing by 12.86% on average per year.
EPS 1Y (TTM)6.82%
EPS 3Y19.28%
EPS 5Y14.07%
EPS Q2Q%0%
Revenue 1Y (TTM)18.79%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%25.92%
3.2 Future
Based on estimates for the next years, DOC will show a very negative growth in Earnings Per Share. The EPS will decrease by -13.40% on average per year.
DOC is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -20.89% yearly.
EPS Next Y-31.69%
EPS Next 2Y-37.33%
EPS Next 3Y-21.19%
EPS Next 5Y-13.4%
Revenue Next Year23.17%
Revenue Next 2Y14.25%
Revenue Next 3Y10.75%
Revenue Next 5Y-20.89%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 44.32, DOC can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as DOC.
DOC is valuated expensively when we compare the Price/Earnings ratio to 28.58, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 94.70, DOC can be considered very expensive at the moment.
DOC's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 24.47. DOC is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.32 | ||
| Fwd PE | 94.7 |
4.2 Price Multiples
DOC's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, DOC is valued a bit cheaper than 64.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.3 | ||
| EV/EBITDA | 14.74 |
4.3 Compensation for Growth
A cheap valuation may be justified as DOC's earnings are expected to decrease with -21.19% in the coming years.
PEG (NY)N/A
PEG (5Y)3.15
EPS Next 2Y-37.33%
EPS Next 3Y-21.19%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.81%, DOC is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 18.24, DOC pays a bit more dividend than its industry peers.
DOC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.81% |
5.2 History
The dividend of DOC decreases each year by -4.01%.
DOC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-4.01%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DOC pays out 242.60% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of DOC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP242.6%
EPS Next 2Y-37.33%
EPS Next 3Y-21.19%
HEALTHPEAK PROPERTIES INC
NYSE:DOC (1/24/2025, 8:04:00 PM)
After market: 20.657 -0.17 (-0.83%)20.83
+0.18 (+0.87%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners93.19%
Inst Owner Change-0.17%
Ins Owners0.3%
Ins Owner Change-3.14%
Market Cap14.57B
Analysts80
Price Target25.77 (23.72%)
Short Float %1.59%
Short Ratio2.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.81% |
Yearly Dividend1.2
Dividend Growth(5Y)-4.01%
DP242.6%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)103.52%
Min EPS beat(2)76.02%
Max EPS beat(2)131.02%
EPS beat(4)3
Avg EPS beat(4)36.89%
Min EPS beat(4)-86.62%
Max EPS beat(4)131.02%
EPS beat(8)5
Avg EPS beat(8)29.65%
EPS beat(12)8
Avg EPS beat(12)61.54%
EPS beat(16)10
Avg EPS beat(16)46.24%
Revenue beat(2)2
Avg Revenue beat(2)2.46%
Min Revenue beat(2)1.94%
Max Revenue beat(2)2.98%
Revenue beat(4)3
Avg Revenue beat(4)3.04%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)7.87%
Revenue beat(8)5
Avg Revenue beat(8)-7.49%
Revenue beat(12)8
Avg Revenue beat(12)-4.75%
Revenue beat(16)12
Avg Revenue beat(16)53.65%
PT rev (1m)-0.52%
PT rev (3m)2.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.28%
EPS NY rev (1m)0%
EPS NY rev (3m)5.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.32 | ||
| Fwd PE | 94.7 | ||
| P/S | 5.7 | ||
| P/FCF | 31.3 | ||
| P/OCF | 14.31 | ||
| P/B | 1.7 | ||
| P/tB | 1.9 | ||
| EV/EBITDA | 14.74 |
EPS(TTM)0.47
EY2.26%
EPS(NY)0.22
Fwd EY1.06%
FCF(TTM)0.67
FCFY3.2%
OCF(TTM)1.46
OCFY6.99%
SpS3.65
BVpS12.24
TBVpS10.96
PEG (NY)N/A
PEG (5Y)3.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 3.61% | ||
| ROCE | 3.2% | ||
| ROIC | 2.53% | ||
| ROICexc | 2.55% | ||
| ROICexgc | 2.82% | ||
| OM | 22.99% | ||
| PM (TTM) | 12.08% | ||
| GM | 64.69% | ||
| FCFM | 18.21% |
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
ROICexc(3y)2.16%
ROICexc(5y)1.9%
ROICexgc(3y)2.33%
ROICexgc(5y)2.05%
ROCE(3y)2.71%
ROCE(5y)2.39%
ROICexcg growth 3Y28.26%
ROICexcg growth 5Y4.6%
ROICexc growth 3Y28.51%
ROICexc growth 5Y3.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 18.44 | ||
| Debt/EBITDA | 5.49 | ||
| Cap/Depr | 56.91% | ||
| Cap/Sales | 21.62% | ||
| Interest Coverage | 2.44 | ||
| Cash Conversion | 65.32% | ||
| Profit Quality | 150.76% | ||
| Current Ratio | 0.15 | ||
| Quick Ratio | 0.15 | ||
| Altman-Z | 0.56 |
F-Score6
WACC7.05%
ROIC/WACC0.36
Cap/Depr(3y)183.97%
Cap/Depr(5y)234.29%
Cap/Sales(3y)65.04%
Cap/Sales(5y)98.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.82%
EPS 3Y19.28%
EPS 5Y14.07%
EPS Q2Q%0%
EPS Next Y-31.69%
EPS Next 2Y-37.33%
EPS Next 3Y-21.19%
EPS Next 5Y-13.4%
Revenue 1Y (TTM)18.79%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%25.92%
Revenue Next Year23.17%
Revenue Next 2Y14.25%
Revenue Next 3Y10.75%
Revenue Next 5Y-20.89%
EBIT growth 1Y39.7%
EBIT growth 3Y27.09%
EBIT growth 5Y6.6%
EBIT Next Year250.9%
EBIT Next 3Y58.01%
EBIT Next 5Y34.66%
FCF growth 1Y185.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.01%
OCF growth 3Y8.03%
OCF growth 5Y2.41%